Physician
Heacock Health Medical Group, INC.
Heacock Health Medical Group, INC. was paid $1.59M by Medicaid between Jul 2020 and Nov 2024, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 18% of everything it billed.
33Billing provider infoHEACOCK HEALTH MEDICAL GROUP, INC.
MORENO VALLEY, CA 92553
MORENO VALLEY, CA 92553
33aNPI1891251849assigned 02/14/2019
33bProvider typeFamily Medicine Physician
28Total paid$1.59M
24GClaims47,540
24DCodes billed32
24AFirst – last monthJul 2020 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#124 of 2,511
Median peer was paid$13K
This provider vs. median124×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,123 | $36K | |
| 2021 | 14,427 | $351K | |
| 2022 | 13,882 | $453K | |
| 2023 | 10,966 | $426K | |
| 2024incomplete | 7,142 | $328K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 7,772 | 7,480 | $286K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 16% | 3,838 | 3,821 | $257K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 6,197 | 5,998 | $213K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 9,086 | 8,333 | $208K |
| 86328 | 12% | 5,605 | 5,469 | $195K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 3,161 | 3,130 | $169K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.9% | 1,343 | 1,289 | $78K |
| 99205 | Prolong outpt/office vis | 3.2% | 596 | 596 | $51K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.1% | 2,967 | 2,885 | $49K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 1,829 | 1,759 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 992 | 931 | $17K |
| 99417 | Prolong home eval add 15m | 1.0% | 583 | 583 | $16K |
20 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 433 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 578 | $11K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 212 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 151 | $1K |
| 81005 | <1% | 780 | $1K | |
| 87400 | <1% | 228 | $1K | |
| 94760 | <1% | 207 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 112 | $718.76 |
| 81000 | <1% | 259 | $647.77 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 47 | $229.26 |
| S9083 | Global fee urgent care centers | <1% | 126 | $90.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 125 | $82.76 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 118 | $75.00 |
| 81003 | <1% | 14 | $19.40 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 15 | $12.45 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 40 | $4.66 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 14 | $3.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 23 | $2.99 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 64 | $2.21 |
| 99401 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPENUNURI, RAFAEL (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Remedial Medical Group | Moreno Valley, CA | $220K |
| Life Health Care Medical Group INC | Santa Ana, CA | $93K |
| Remedial Patients Care INC | Corona, CA | $42K |
| Superior Family Medical Group INC | Newport Beach, CA | $33K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.